Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Effect of Vitamin D Supplementation in Type 2 Diabetes Patients with Tuberculosis: A Systematic Review

Author(s): Divya Girishbhai Patel, Shilia Jacob Kurian, Sonal Sekhar Miraj*, Muhammed Rashid, Levin Thomas, Gabriel Sunil Rodrigues, Mithu Banerjee, Bidita Khandelwal, Kavitha Saravu and Mahadev Rao

Volume 18, Issue 4, 2022

Published on: 06 January, 2022

Article ID: e020921196096 Pages: 11

DOI: 10.2174/1573399817666210902144539

Price: $65

Abstract

Background: Diabetes mellitus (DM) and tuberculosis (TB) have been recognized as reemerging epidemics, especially in developing countries. Among all the risk factors, diabetes causes immunosuppression, increasing the risk of active TB three times. Vitamin D has been found as a link between DM-TB co-morbidity.

Objective: Vitamin D affects the immune response, suppresses Mycobacterium tuberculosis (Mtb) growth, and affects insulin secretion. The present systematic review determines the effect of vitamin D supplementation on clinical and therapeutic outcomes of DM-TB patients.

Method: A comprehensive literature search was carried out in PubMed, Cochrane, Web of Science, and Scopus database to determine eligible studies from inception to January 2021. Out of the 639 articles retrieved, three randomized controlled trials (RCTs) were included in the systematic review.

Result: The effect of vitamin D3 or oral cholecalciferol supplementation was assessed on outcomes, such as duration to sputum smear conversion, TB scores improvement, change in glycemic parameters, including HbA1c, FBS, and PLBS, and laboratory parameters, such as Hb, ESR, and CRP. Duration of sputum smear conversion was decreased by two weeks in the vitamin D3 supplemented group in two studies. TB score improvement and changes in glycemic parameters were inclined towards supplemented group; however, they were not significant.

Conclusion: The overall effect of vitamin D3 supplementation on TB patients with DM was not significant. Further studies are required in the future examining the effect of supplementation on outcomes in this population.

Keywords: Diabetes mellitus, tuberculosis, vitamin D3 supplement, TB score, sputum smear conversion, systematic review.

[1]
Global tuberculosis report 2020. World Health Organization. 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
[2]
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843.
[http://dx.doi.org/10.1016/j.diabres.2019.107843] [PMID: 31518657]
[3]
Tuberculosis & diabetes facts. World Health Organization. 2016. Available from: https://www.who.int/tb/publications/diabetes_tb.pdf
[4]
Global tuberculosis report 2020. 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
[5]
Chumburidze-Areshidze N, Kezeli T, Avaliani Z, Mirziashvili M, Avaliani T, Gongadze N. The relationship between type-2 diabetes and tuberculosis. Georgian Med News 2020; (300): 69-74.
[PMID: 32383705]
[6]
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9(12): 737-46.
[http://dx.doi.org/10.1016/S1473-3099(09)70282-8] [PMID: 19926034]
[7]
Pizzol D, Di Gennaro F, Chhaganlal KD, et al. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health 2016; 21(6): 694-702.
[http://dx.doi.org/10.1111/tmi.12704] [PMID: 27102229]
[8]
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014; 21(3): 319-29.
[http://dx.doi.org/10.1016/j.chembiol.2013.12.016] [PMID: 24529992]
[9]
Zhao X, Yuan Y, Lin Y, et al. Vitamin D status in tuberculosis patients with diabetes, prediabetes and normal blood glucose in China: A cross-sectional study. BMJ Open 2017; 7(9): e017557.
[http://dx.doi.org/10.1136/bmjopen-2017-017557] [PMID: 28951414]
[10]
Zhao X, Yuan Y, Lin Y, et al. Vitamin D status of tuberculosis patients with diabetes mellitus in different economic areas and associated factors in China. PLoS One 2018; 13(11): e0206372.
[http://dx.doi.org/10.1371/journal.pone.0206372] [PMID: 30383776]
[11]
Zhang Y, Jiang X, Li X, et al. Serum vitamin D levels and risk of liver cancer: A systematic review and dose-response meta-analysis of cohort studies. Nutr Cancer 2021; 73(8): 1-9.
[http://dx.doi.org/10.1080/01635581.2020.1797127] [PMID: 32705896]
[12]
McCullough ML, Zoltick ES, Weinstein SJ, et al. Circulating vitamin D and colorectal cancer risk: An international pooling project of 17 cohorts. J Natl Cancer Inst 2019; 111(2): 158-69.
[http://dx.doi.org/10.1093/jnci/djy087] [PMID: 29912394]
[13]
Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin d deficiency and tuberculosis progression. Emerg Infect Dis 2010; 16(5): 853-5.
[http://dx.doi.org/10.3201/eid1605.091693] [PMID: 20409383]
[14]
Kearns MD, Tangpricha V. The role of vitamin D in tuberculosis. J Clin Transl Endocrinol 2014; 1(4): 167-9.
[http://dx.doi.org/10.1016/j.jcte.2014.08.002] [PMID: 29159097]
[15]
Junaid K, Rehman A. Impact of vitamin D on infectious disease- tuberculosis-a review. Clin Nutr Exp 2019; 25: 1-10.
[http://dx.doi.org/10.1016/j.yclnex.2019.02.003]
[16]
Hu Q, Chen Z, Liang G, et al. Vitamin D receptor gene associations with pulmonary tuberculosis in a Tibetan Chinese population. BMC Infect Dis 2016; 16(1): 469.
[http://dx.doi.org/10.1186/s12879-016-1699-4] [PMID: 27595605]
[17]
Coussens A, Timms PM, Boucher BJ, et al. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009; 127(4): 539-48.
[http://dx.doi.org/10.1111/j.1365-2567.2008.03024.x] [PMID: 19178594]
[18]
Zhang J, Chen C, Yang J. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: A meta-analysis of randomized controlled trials. Chin Med J (Engl) 2019; 132(24): 2950-9.
[http://dx.doi.org/10.1097/CM9.0000000000000554] [PMID: 31833904]
[19]
Seshadri KG, Tamilselvan B, Rajendran A. Role of vitamin D in diabetes. J Endocrinol Metab 2011; 1(2): 47-56.
[20]
Schuch NJ, Garcia VC, Vívolo SRGF, Martini LA. Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome. Nutr J 2013; 12: 96.
[http://dx.doi.org/10.1186/1475-2891-12-96] [PMID: 23855914]
[21]
Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P. Vitamin D and glycemic control in diabetes mellitus type 2. Ther Adv Endocrinol Metab 2013; 4(4): 122-8.
[http://dx.doi.org/10.1177/2042018813501189] [PMID: 23997931]
[22]
Hu Z, Chen J, Sun X, Wang L, Wang A. Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies. Medicine (Baltimore) 2019; 98(14): e14970.
[http://dx.doi.org/10.1097/MD.0000000000014970] [PMID: 30946322]
[23]
Kota SK, Jammula S, Kota SK, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr 2011; 5(2): 85-9.
[http://dx.doi.org/10.1016/j.dsx.2012.02.021] [PMID: 22813409]
[24]
Wang Q, Ma A, Schouten EG, Kok FJ. A double burden of tuberculosis and diabetes mellitus and the possible role of vitamin D deficiency. Clin Nutr 2021; 40(2): 350-7.
[http://dx.doi.org/10.1016/j.clnu.2020.08.040] [PMID: 32948348]
[25]
Patel D, Kurian S, Thomas L. Sonal Sekhar MRao.. Effect of vitamin D supplementation on type 2 diabetes patients with tuberculosis: A systematic review. PROSPERO 2020 CRD42020211189, 2020. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020211189
[26]
WHO consolidated guidelines on drug-resistant tuberculosis treatment [Internet]. 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf?ua=1
[27]
Howick J. Glasziou P CI The oxford 2011 levels of evidence. Oxford, UK: Oxford Centre for Evidence-Based Medicine 2011.
[28]
Chapter 8: Assessing risk of bias in a randomized trial | Cochrane Training [Internet]. Available from: https://training.cochrane.org/handbook/current/chapter-08
[29]
Alam M, Tahir A, Ullah R. Effect of vitamin D supplements and pulmonary tuberculosis prognosis in known diabetic patients. Pak J Med Health Sci 2019; 13(4): 903-5.
[30]
Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 diabetes mellitus, insulin resistance, and vitamin D. Curr Diab Rep 2019; 19(10): 101.
[http://dx.doi.org/10.1007/s11892-019-1201-y] [PMID: 31506836]
[31]
Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79(5): 820-5.
[http://dx.doi.org/10.1093/ajcn/79.5.820] [PMID: 15113720]
[32]
Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The Effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Nutrients 2018; 10(3): 375.
[http://dx.doi.org/10.3390/nu10030375] [PMID: 29562681]
[33]
Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications 2017; 31(7): 1115-26.
[http://dx.doi.org/10.1016/j.jdiacomp.2017.04.019] [PMID: 28483335]
[34]
Wallace HJ, Holmes L, Ennis CN, et al. Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2019; 110(5): 1138-47.
[http://dx.doi.org/10.1093/ajcn/nqz171] [PMID: 31559433]
[35]
Moreira-Lucas TS, Duncan AM, Rabasa-Lhoret R, et al. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab 2017; 19(1): 133-41.
[http://dx.doi.org/10.1111/dom.12794] [PMID: 27717236]
[36]
Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 2019; 381(6): 520-30.
[http://dx.doi.org/10.1056/NEJMoa1900906] [PMID: 31173679]
[37]
Panierakis C, Goulielmos G, Mamoulakis D, Petraki E, Papavasiliou E, Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol 2009; 133(2): 276-81.
[http://dx.doi.org/10.1016/j.clim.2009.08.004] [PMID: 19734102]
[38]
Wu H-X, Xiong X-F, Zhu M, Wei J, Zhuo K-Q, Cheng D-Y. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: A systematic review and meta-analysis. BMC Pulm Med 2018; 18(1): 108.
[http://dx.doi.org/10.1186/s12890-018-0677-6] [PMID: 29954353]
[39]
Wang J, Feng M, Ying S, Zhou J, Li X. Efficacy and Safety of Vitamin D supplementation for pulmonary tuberculosis: A systematic review and meta-analysis. Iran J Public Health 2018; 47(4): 466-72.
[PMID: 29900130]
[40]
Xia J, Shi L, Zhao L, Xu F. Impact of vitamin D supplementation on the outcome of tuberculosis treatment: A systematic review and meta-analysis of randomized controlled trials. Chin Med J (Engl) 2014; 127(17): 3127-34.
[PMID: 25189958]
[41]
Daley P, Jagannathan V, John KR, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: A randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2015; 15(5): 528-34.
[http://dx.doi.org/10.1016/S1473-3099(15)70053-8] [PMID: 25863562]
[42]
Grobler L, Nagpal S, Sudarsanam TD, Sinclair D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2016; 2016(6): CD006086.
[http://dx.doi.org/10.1002/14651858.CD006086.pub4] [PMID: 27355911]
[43]
Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 2011; 377(9761): 242-50.
[http://dx.doi.org/10.1016/S0140-6736(10)61889-2] [PMID: 21215445]
[44]
Wang Q, Ma A, Han X, et al. Is low serum 25-hydroxyvitamin D a possible link between pulmonary tuberculosis and type 2 diabetes? Asia Pac J Clin Nutr 2017; 26(2): 241-6.
[PMID: 28244701]
[45]
Chaudhary S, Thukral A, Tiwari S, Pratyush DD, Singh SK. Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis. Indian J Endocrinol Metab 2013; 17(Suppl. 3): S670-3.
[http://dx.doi.org/10.4103/2230-8210.123564] [PMID: 24910835]
[46]
Wang Q, Liu Y, Ma Y, et al. Severe hypovitaminosis D in active tuberculosis patients and its predictors. Clin Nutr 2018; 37(3): 1034-40.
[http://dx.doi.org/10.1016/j.clnu.2017.04.018] [PMID: 28514999]
[47]
Bellamy R. Evidence of gene-environment interaction in development of tuberculosis. Lancet 2000; 355(9204): 588-9.
[http://dx.doi.org/10.1016/S0140-6736(99)00426-2] [PMID: 10696972]
[48]
Roth DE, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004; 190(5): 920-7.
[http://dx.doi.org/10.1086/423212] [PMID: 15295697]
[49]
Babb C, van der Merwe L, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb) 2007; 87(4): 295-302.
[http://dx.doi.org/10.1016/j.tube.2007.03.001] [PMID: 17449323]
[50]
Magee MJ, Sun YV, Brust JCM, et al. Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa. PLoS One 2017; 12(7): e0180916.
[http://dx.doi.org/10.1371/journal.pone.0180916] [PMID: 28700743]
[51]
Lee YH, Song GG. Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: A meta-analysis. Genet Mol Res 2015; 14(3): 9118-29.
[http://dx.doi.org/10.4238/2015.August.7.21] [PMID: 26345844]
[52]
Mohammadi A, Khanbabaei H, Nasiri-Kalmarzi R, Khademi F, Jafari M, Tajik N. Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian population: A systematic review and meta-analysis. J Microbiol Immunol Infect 2020; 53(6): 827-35.
[http://dx.doi.org/10.1016/j.jmii.2019.08.011] [PMID: 31740220]
[53]
Li L, Wu B, Liu J-Y, Yang L-B. Vitamin D receptor gene polymorphisms and type 2 diabetes: A meta-analysis. Arch Med Res 2013; 44(3): 235-41.
[http://dx.doi.org/10.1016/j.arcmed.2013.02.002] [PMID: 23506721]
[54]
India TB report 2020. Ministry of Health and Family Welfare 2020. Available from: https://tbcindia.gov.in/showfile.php?lid=3538
[55]
Members [Internet]. Available from: https://idf.org/our-network/regions-members/south-east-asia/members/94-india.html
[56]
G R, Gupta A. Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients 2014; 6(2): 729-75.
[http://dx.doi.org/10.3390/nu6020729] [PMID: 24566435]
[57]
Kamboj P, Dwivedi S, Toteja GS. Prevalence of hypovitaminosis D in India & way forward. Indian J Med Res 2018; 148(5): 548-56.
[http://dx.doi.org/10.4103/ijmr.IJMR_1807_18] [PMID: 30666982]
[58]
Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int J Epidemiol 2008; 37(1): 113-9.
[http://dx.doi.org/10.1093/ije/dym247] [PMID: 18245055]
[59]
Herrera MT, Gonzalez Y, Hernández-Sánchez F, Fabián-San Miguel G, Torres M. Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity. BMC Infect Dis 2017; 17(1): 610.
[http://dx.doi.org/10.1186/s12879-017-2705-1] [PMID: 28882103]
[60]
Wang Q, Ma A, Gao T, et al. Poor vitamin D status in active pulmonary tuberculosis patients and its correlation with leptin and TNF-α. J Nutr Sci Vitaminol (Tokyo) 2019; 65(5): 390-8.
[http://dx.doi.org/10.3177/jnsv.65.390] [PMID: 31666475]
[61]
Zhang X, Ma A, Sun S, Sun Y. Proteomic analysis of plasma in adult active pulmonary tuberculosis patients with diabetes mellitus. Clin Lab 2015; 61(10): 1481-90.
[http://dx.doi.org/10.7754/Clin.Lab.2015.150210] [PMID: 26642710]
[62]
Wang Z, Lin YS, Zheng XE, et al. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol 2012; 81(4): 498-509.
[http://dx.doi.org/10.1124/mol.111.076356] [PMID: 22205755]
[63]
Polasa K, Murthy KJ, Krishnaswamy K. Rifampicin kinetics in undernutrition. Br J Clin Pharmacol 1984; 17(4): 481-4.
[http://dx.doi.org/10.1111/j.1365-2125.1984.tb02377.x] [PMID: 6721995]
[64]
Naik AL, Rajan MG, Manjrekar PA, et al. Effect of DOTS treatment on vitamin D levels in pulmonary tuberculosis. J Clin Diagn Res 2017; 11(4): BC18-22.
[http://dx.doi.org/10.7860/JCDR/2017/24501.9759] [PMID: 28571130]
[65]
Lopez-Lopez N, Gonzalez-Curiel I, Castañeda-Delgado J, et al. Vitamin D supplementation promotes macrophages’ anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression. Microbes Infect 2014; 16(9): 755-61.
[http://dx.doi.org/10.1016/j.micinf.2014.06.010] [PMID: 25016144]
[66]
Sudfeld CR, Mugusi F, Muhihi A, et al. Efficacy of vitamin D3 supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: A randomised, double-blind, placebo-controlled trial. Lancet HIV 2020; 7(7): e463-71.
[http://dx.doi.org/10.1016/S2352-3018(20)30108-9] [PMID: 32621874]
[67]
Seida JC, Mitri J, Colmers IN, et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2014; 99(10): 3551-60.
[http://dx.doi.org/10.1210/jc.2014-2136] [PMID: 25062463]
[68]
Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta- analyses and randomised trials. Lancet Diabetes Endocrinol 2017; 5(12): 986-1004.
[http://dx.doi.org/10.1016/S2213-8587(17)30357-1] [PMID: 29102433]

Rights & Permissions Print Cite
Article Metrics
44
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy